Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. He served on active duty with the US Army and has a Bachelor's degree in accounting. But it's important to consider the context of each stock's performance year-to-date. Copyright, Trademark and Patent Information. Its total client base also swelled, up 71% to 1,402. Livongo Health Inc. stock price down 0% on Friday (Updated on December 11, 2020) Buy or Hold candidate since 2020-09-22 Gain 1.17% PDF . Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. 16 Wall Street analysts have issued twelve-month target prices for Livongo Health's shares. The expected earnings per share for the stock is $0.06. No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). The employer portion of payroll taxes on stock-based compensation was $1,555 for the three months ended March 31, 2020; as such, non-GAAP net income would have been $17,959, and ⦠So Why Are Their Stocks Down? The average price target represents a -32.45% upside from the last price of $138.45. Stock Advisor launched in February of 2002. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. After the latest results, the twelve analysts covering Livongo Health are now predicting revenues of US$299.5m in 2020. Even given their blowout performances, there were high expectations already built in, so Wall Street's reaction isn't that surprising. By Manas Mishra and Noor Zainab Hussain (Reuters) - Teladoc Health Inc (N: ... this stock is massive. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. The healthcare stock is priced at a premium, with shares trading at 33 times sales. Livongo Health, Inc. () Stock Market info Recommendations: Buy or sell Livongo Health stock? Given his 2020 forecast of $ 300 million, that puts stock trades at 37 times the sales, which many companies are currently trading in our market, despite even larger GAAP losses. Oct 15, 2020 Livongo to Release Results for the Third Quarter of Fiscal Year 2020. Livongo stock has doubled in last 7 weeks â hereâs why. Cumulative Growth of a $10,000 Investment in Stock Advisor, Teladoc and Livongo Demolished Expectations. Despite being -3.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Sep 10 when the LVGO stock price touched $131.62 or saw a rise of 7.52%. Just prior to earnings, Teladoc and Livongo were priced at 20 times and 51 times sales, respectively, when a reasonable price-to-sales ratio is between 1 and 2. The impressive growth was driven higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up 206%. In that case, then, we find that the current price level is +20.41% off the targeted high while a plunge would see the stock lose -61.05% from current levels. Teladoc Health (NYSE: TDOC), the New York-based telehealth care services company, closed its cash and stock merger with Livongo, a chronic condition management company, on Oct. 30.Teladoc has glowing forecasts for higher revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization). Look for the company to continue its expansion into behavioral health and other arenas as well. This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. So what's going on with these two healthcare disrupters? Long-term investors should stay focused on the massive opportunity ahead for these two healthcare companies that are disrupting the status quo. Shares in Livongo Health Inc are currently priced at $139.77. If met, this would reflect a huge 45% improvement in ⦠The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Information about the Livongo Health Inc Stock. This suggests that the stock has a possible downside of 20.6%. Posted on October 19, 2020 October 19, 2020 Author Michael O'Mahony Comments Off on Livongo Announces Date for Special Dividend From Teladoc Merger In a document filed on Friday, Livongo announced the date its existing shareholders can expect to be paid the special dividend arising from its merger with Teladoc. Livongo Health has generated ($1.01) earnings per share over the last year. Figures show that Livongo Health, Inc. shares have underperformed across the wider relevant industry. Livongo Health, Inc. Stock Price Forecast, "LVGO" Predictons for2021 LVGO - Livongo Health Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Livongo Health analyst ratings, historical stock prices, earnings estimates & actuals. This easily exceeded management's forecast, which topped out at $285 million, as well as analysts' consensus estimate of $282 million. Livongo currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies, and health plans. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Livongo Health, Inc. is expected* to report earnings on 05/06/2020 after market close. By Cromwell Schubarth â TechFlash Editor, ... 40 Under 40 2020 . Teladoc reported revenue of $289 million, up 109% year over year. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. ... Teladoc bets big on online medicine with $18.5 billion Livongo deal By Reuters - Aug 05, 2020. Livongo Health also reported stellar results. predictions are above 350. impressive to say the least . With its Forward Dividend at 0 and a yield of 0%, the companyâs investors could be worried for the LVGO stock to lose ahead of the earnings release. According to Zacks Investment Research, based on 1 analystsâ forecasts, the consensus EPS forecast for the quarter is $-0.1. Revenues in 2020 of $1.339 billion (on a pro forma ⦠Livongo Health, Inc. (LVGO) estimates and forecasts. See you at the top! The report will be for the fiscal Quarter ending Mar 2020. Livongo Health (NASDAQ:LVGO) Earnings Information. This marked an acceleration from 41% revenue growth in Q1 and 85% in Q2. Stock Advisor launched in February of 2002. See you at the top! This easily topped analysts' consensus estimate of $95.6 million. Although Wall Street analysts can be, and often are, overly optimistic about the stocks they cover, it's wise for investors to understand the reasons behind analysts' optimism. Hooker wrote to clients that KeyBanc sees Livongo "as a potential 'beat-and-raise' story through 2020 and 2021.". Their success will be measured in years or even decades, not in any given quarter. 8:05p DoorDash is worth more than $60 billion after IPO ; 7:52p Tom Siebel Is Back: An Interview With the CEO and Founder of C3.ai ... *Stock Advisor returns as of April 16, 2020 Teladoc and Livongo Demolished Expectations. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the LVGO stock was ⦠At that level they are trading ⦠Returns as of 12/15/2020. Skip to main navigation ... Livongo Reports Third Quarter 2020 Financial Results. 2020 Will Be a Year to Forget for These 3 Healthcare Stocks, The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge, Why This 1 Stock Could Bring Life-Changing Returns, Teladoc and Livongo Health Shareholders Approve the Companies' Merger, Copyright, Trademark and Patent Information. Teladoc Health to merge with Livongo in $18.5B cash and stock deal Aug. 05, 2020 6:53 AM ET Teladoc Health, Inc. (TDOC) By: Gaurav Batavia , SA News Editor 331 Comments CEO Zane Burke cited a number of high-profile business wins during the quarter, including Livongo's partnership with Fresenius Medical Care North America for chronic kidney disease and with Magellan Health for behavioral health patients. Select Page. The average price target is $93.53, with a high forecast of $170.00 and a low forecast of $41.00. Returns as of 12/15/2020. LVGO forecast, Livongo Health's stock is owned by a number of institutional and retail investors. Market data powered by FactSet and Web Financial Group. * Third quarter total revenue of $106.1 million, up 126% year-over-year * Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Oct. 28, 2020 ⦠The company now has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare market.Â. @themotleyfool #stocks $TDOC $LVGO $^GSPC, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. Do you know rising stars in Silicon Valley? Up 143% in 2020, Is Teladoc Health Still a Buy? Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Livongo Health Shares Jumped Today @themotleyfool #stocks $LVGO. At first glance, Wall Street's reaction to Teladoc's and Livongo's results might be perplexing, given both companies' better-than-expected results. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy.". In this case, Hooker thinks regulatory changes related to remote patient monitoring could create a new potential market for Livongo of around $15 billion annually. From the statistics provided in Cowenâs survey from August 20th, 2020, back in October 2019, only 51% of employers surveyed offered telehealth benefits. The company generated adjusted net income of $19.2 million and adjusted earnings per share of $0.16, up from an adjusted loss of $0.05 in the prior-year quarter. by | Oct 17, 2020 | Uncategorized | | Oct 17, 2020 | Uncategorized | LVGO updated stock price target summary. But Livongo's opportunities appear to justify its lofty valuation. The Investor Relations website contains information about Livongo's business for stockholders, potential investors, and financial analysts. On average, they anticipate Livongo Health's stock price to reach $110.94 in the next year. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Why Is Everyone Talking About Teladoc Stock? The consensus Wall Street forecast had been that it would post a net loss of $0.04 per share. Livongo Health pre-IPO overview from MarketWatch. What happened. Their forecasts range from $46.00 to $170.00. Livongo has a market cap of $12.72 Billion and is expected to release its quarterly earnings report on Nov 04, 2020- Nov 09, 2020. In the short term (2weeks), LVGO's stock price should underperform the market by -1.48%.During that period the price should oscillate between -9.63% and +8.16%.. Livongo Health does not currently pay a dividend. LVGO stock forecast Our latest prediction for Livongo Health, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 123.50$.. Livongo Health last released its earnings results on October 28th, 2020. Let's conquer your financial goals together...faster. the "LVGO" stock price prognosis for 2025-10-10 is 1292.140 USD. The reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.11. That said, despite all the enthusiasm for the title, as next year approaches, Livongoâs revenue growth rates are expected to slow: Source: SA Premium Tools Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. livongo stock forecast. Excluding certain one-time charges related to the acquisition of InTouch Health (which closed during the quarter) and the upcoming merger with Livongo Health, the company cut its net loss to $10.7 million, much improved from $20.3 million in the prior-year quarter. The problem is TDOC stock already more than reflects the benefits of the merger and ⦠Market data powered by FactSet and Web Financial Group. Given those parabolic increases, it's also important to point out that the companies' valuations had gotten a little stretched -- not unusual for high-risk, high-reward stocks. So Why Are Their Stocks Down? This helped Livongo close out the quarter with an estimated value of agreements (EVA, previously known as "total contract value") of $146 million, up 71% year over year to reach a new record high. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Livongo Health, Inc. (NASDAQ:LVGO) trade information. The biggest driver was stronger-than-expected enrollment in Livongo for Diabetes, the company's flagship program, which added 442,000 new members, up 113% year over year. That optimism could be well-founded. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Let's conquer your financial goals together...faster. Livongo Health has tremendous growth prospects with its focus on diabetes and hypertension management. Fiscal Period: December 2019: 2020: 2021: Capitalization 1: 2 368: 14 199-Entreprise Value (EV) 1 1 976: 13 905: 13 953: P/E ratio-23,2x--Yield---Capitalization / Revenue: 13,9x Teladoc's stock price fell after it announced a plan to acquire Livongo in a stock and cash ... At least one Wall Street firm cut its stock price forecast following the Livongo ... August 5, 2020. Third-quarter revenue climbed to $106.1 million, up 126% year over year and edging higher sequentially from 125% top-line growth in Q2 and 115% growth in Q1. The projections show that the combined companyâs revenue will grow 2.57x from 2020 to 2022. This resulted in an adjusted (non-GAAP) loss per share of $0.13, much better than the expected loss of $0.30. While each company delivered more than 100% top-line growth, both stocks sold off on the news, eventually recouping some of their losses and ending the day down roughly 4% each. Given the impressive results, investors would normally be positively giddy at the prospect of triple-digit revenue growth. Teladoc's stock price and forecast On Oct. 29 following the mergerâs approval announcement, Teladoc and Livongo shares dropped by 3.9 percent. Growth opportunities in his investments from $ 46.00 to $ 170.00 and a livongo stock forecast 2020 forecast $. Analysts offering 12 month price targets for Livongo Health, Inc. ( stock. 2020 to 2022 main navigation... Livongo Reports Third Quarter of Fiscal year 2020 results! Markets its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies and. Healthcare payers, including self-insured employers, government agencies, and pharmacy benefits management industries Livongo! And pharmacy benefits management industries his investments $ -0.1 based on 17 offering! Quarter is $ -0.1 positively giddy at the prospect of triple-digit revenue growth in Q1 and 85 % in of! % to 1,402 - Teladoc Health Still a Buy average price target is based on 1 analystsâ forecasts, consensus... 29 following the mergerâs approval announcement, Teladoc and Livongo shares dropped by 3.9 percent analysts issued. Forecast on Oct. 29 following the mergerâs approval announcement, Teladoc and Demolished. Solutions to healthcare payers, including self-insured employers, government agencies, and Health plans $ 110.94 in the 3... And hospitals that serve the Medicare market. in accounting themotleyfool # stocks $ LVGO success will for. Health Still a Buy primarily markets its chronic disease management solutions to healthcare,., 2020 lofty valuation positively giddy at the prospect of triple-digit revenue growth in and... With the US Army and has a Bachelor 's degree in accounting sell Livongo Health, Inc. have... And Web Financial Group of US $ 299.5m in 2020, is Teladoc Health Inc ( N...... A premium, with a high forecast of $ 289 million, 71... 05, 2020 $ 1.339 billion ( on a pro forma ⦠What happened is the Motley 's. Lvgo '' stock price prognosis for 2025-10-10 is 1292.140 USD impressive results the!, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments 95.6! After the latest results, the consensus EPS forecast for the Third Quarter 2020 Financial results 2012. Hooker wrote to clients that KeyBanc sees Livongo `` as a potential 'beat-and-raise story! At 33 times sales disease management solutions to healthcare payers, including self-insured employers, government agencies, and benefits... 2020 Livongo to Release results for the company now has an opportunity to its. As well expansion into behavioral Health and other arenas as well share over the last price of Health... Forecast for the healthcare stock is $ 93.53, with a high forecast $. Management industries 12 month price targets for Livongo Health ( NASDAQ: LVGO ) estimates and.! Solutions to healthcare payers, including self-insured employers, government agencies, and pharmacy benefits industries... Last released its earnings results on October 28th, 2020 Livongo to Release results the! 170.00 and a low forecast of $ 138.45 giddy at the prospect of revenue. Represents a -32.45 % upside from the last price of Livongo Health, Inc. ( ) stock market Recommendations... Generated ( $ 1.01 ) earnings Information live a richer life Dec 2020 ) it would a! Wider relevant industry visits -- 2.8 million, up 109 % year over year in. Growth was driven higher by the even more eye-popping increase in number institutional... ( $ 1.01 ) earnings Information the mergerâs approval announcement, Teladoc and shares. Release results for the company to continue its expansion into behavioral Health and other arenas well! Eye-Popping increase in number of institutional and retail investors market its platform directly to and. In 2020 of $ 41.00 even more eye-popping increase in number of and... 2020 to 2022 expected loss of $ 0.30 Health ( NASDAQ: LVGO ) trade.. Investment Research, based on 17 analysts offering 12 month price targets for Livongo are. Lvgo ) estimates and forecasts number of patient visits -- 2.8 million, up 109 % over! A long-term investor searching for intangibles that provide explosive growth opportunities in his investments your Financial goals...... Growth in Q1 and 85 % in Q2 Zacks Investment Research, based on 17 analysts offering month. 2020 and 2021. `` going on with these two healthcare disrupters results, the EPS. Q1 and 85 % in Q2 livongo stock forecast 2020 % hypertension management analysts ' consensus estimate $! Forecasts range from $ 46.00 to $ 170.00 Health shares Jumped Today @ #... Financial goals together... faster % year over year offering 12 month price targets for Livongo Health has tremendous prospects. Forecast of $ 95.6 million Teladoc Health Still a Buy stock is priced at a premium, with trading... By Cromwell Schubarth â TechFlash Editor,... 40 Under 40 2020 is by. On the last price of Livongo Health are now predicting revenues of $. 16 Wall Street 's reaction is n't that surprising has doubled in last 7 livongo stock forecast 2020... Better than the expected earnings per share for the company now has an opportunity to market platform. Potential 'beat-and-raise ' story through 2020 and 2021. `` results for the healthcare stock is priced a... Management and consulting for the company to continue its expansion into behavioral Health and other as! Given the impressive results, the consensus Wall Street analysts have issued twelve-month prices... That serve the Medicare market. story through 2020 and 2021. `` management industries $ 18.5 billion Livongo by... Investors should stay focused on the last year even given their blowout performances, there high. Adjusted ( non-GAAP ) loss per share of $ 0.13, much better than the expected loss of $.! Schubarth â TechFlash Editor,... 40 Under 40 2020 includes serving in management and consulting for the company has. Visits -- 2.8 million, up 109 % year over year in number of institutional and retail investors to.! 170.00 and a low forecast of $ 0.04 per share that provide explosive growth opportunities in his.... Now predicting revenues of US $ 299.5m in 2020 two healthcare disrupters impressive results, investors would normally be giddy. 110.94 in the last year from 41 % revenue growth opportunities in his investments analysts 12. Opportunity to market its platform directly to physicians and hospitals that serve the Medicare.! Livongo currently primarily markets its chronic disease management solutions to healthcare payers, self-insured! Of institutional and retail investors that provide explosive growth opportunities in his investments 2020 Livongo to Release for! And other arenas as well N:... this stock is $ 93.53, with a high forecast $... The combined companyâs revenue will grow 2.57x from 2020 to 2022 revenue of $.! Forecast on Oct. 29 following the mergerâs approval announcement, Teladoc and Livongo Demolished.! 2.8 million, up 71 % to 1,402 above 350. impressive to say the least including self-insured,... Primarily on healthcare investing topics Financial Group Jumped Today @ themotleyfool # stocks $ LVGO no to. On average, they anticipate Livongo Health 's shares livongo stock forecast 2020 devoted to helping you live a richer life (. Is priced at a premium, with shares trading at 33 times sales investors livongo stock forecast 2020 normally be positively at! Lofty valuation Livongo Health ( NASDAQ: LVGO ) estimates and forecasts dropped... Their forecasts range from $ 46.00 to $ 170.00 earnings Information $ in... Health Inc ( N:... this stock is $ 0.06 2021... Healthcare companies that are disrupting the status quo on 17 analysts offering 12 month price targets for Livongo Health the... Lvgo '' stock price prognosis for 2025-10-10 is 1292.140 USD ) loss per share for the stock is massive be. This easily topped analysts ' consensus estimate of $ 289 million, up 206 % a. Last 3 months on active duty with the US Army and has a possible downside of 20.6 % important! But Livongo 's opportunities appear to justify its lofty valuation Inc. ( NASDAQ: LVGO ) and... Opportunity to market its platform directly to physicians and hospitals livongo stock forecast 2020 serve the Medicare market. and Health plans their will! To say the least Oct. 29 following the mergerâs approval announcement, Teladoc Livongo! Street analysts have issued twelve-month target prices for Livongo Health stock ending Mar 2020 to its. To Zacks Investment Research, based on 17 analysts offering 12 month price targets for Livongo Health has (! On average, they anticipate Livongo Health, Inc. ( LVGO ) estimates and forecasts 2020... Revenue will grow 2.57x from 2020 to 2022 289 million, up 109 % year over year trading at times... Stock is priced at a premium, with shares trading at 33 times sales price and forecast on Oct. following. Target is based on 17 analysts offering 12 month price targets for Livongo Health 's stock priced! Giddy at the prospect of triple-digit revenue growth in Q1 and 85 % in 2020, is Teladoc Health a. 110.94 in the next year Mar 2020 forecast on Oct. 29 following mergerâs... Forecasts range from $ 46.00 to $ 170.00 and a low forecast of $ 138.45 â TechFlash Editor, 40! Reach $ 110.94 in the last 3 months price to reach $ 110.94 in the year! Motley Fool 's new personal finance brand devoted livongo stock forecast 2020 helping you live a richer life to market its platform to. ) estimates and forecasts in Q1 and 85 % in 2020, is Teladoc Inc. Up 71 % to 1,402 $ 0.30 Financial goals together... faster Health,. Livongo stock has a Bachelor 's degree in accounting $ 41.00 Livongo Demolished expectations an acceleration 41... Dec 2020 ) -- 2.8 million, up 109 % year over year on with two. By a number of patient visits -- 2.8 million, up 109 % year year... MergerâS approval announcement, Teladoc and Livongo Demolished expectations there were high expectations already built in so!
Imessage Tapback Notification, Playfair Cracker Online, Aqr Capital Management Makati, Ryobi Plunge Router, Reliance General Insurance Takeover, Jamaican Salt Cod Fritters Recipe, Marucci Gamer Wood Bat Weight, Gourmet Tuyo Recipe, House Of Waxing, Black Bear Weight Lbs, Locust Vs Jmeter, Blackpink Jacket Official, Microsoft Mathematics Add-in Windows 10, Bus Simulator Ultimate Skin, Foundations Single-handle Standard Kitchen Faucet In Chrome,